OtherInflammation and Immunopharmacology
The orally available Syk kinase inhibitor BAY 61-3606 blocks antigen-induced airway inflammation in rodents
Noriyuki Yamamoto, Keisuke Takeshita, Michitaka Shichijo, Toshio Kokubo, Masako Sato, Kosuke Nakashima, Mina Ishimori, Hiroichi Nagai, Ying-Fu Li, Takeshi Yura and Kevin B. Bacon
Journal of Pharmacology and Experimental Therapeutics May 23, 2003, DOI: https://doi.org/10.1124/jpet.103.052316
Noriyuki Yamamoto
Keisuke Takeshita
Michitaka Shichijo
Toshio Kokubo
Masako Sato
Kosuke Nakashima
Mina Ishimori
Hiroichi Nagai
Ying-Fu Li
Takeshi Yura
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherInflammation and Immunopharmacology
The orally available Syk kinase inhibitor BAY 61-3606 blocks antigen-induced airway inflammation in rodents
Noriyuki Yamamoto, Keisuke Takeshita, Michitaka Shichijo, Toshio Kokubo, Masako Sato, Kosuke Nakashima, Mina Ishimori, Hiroichi Nagai, Ying-Fu Li, Takeshi Yura and Kevin B. Bacon
Journal of Pharmacology and Experimental Therapeutics May 23, 2003, DOI: https://doi.org/10.1124/jpet.103.052316
OtherInflammation and Immunopharmacology
The orally available Syk kinase inhibitor BAY 61-3606 blocks antigen-induced airway inflammation in rodents
Noriyuki Yamamoto, Keisuke Takeshita, Michitaka Shichijo, Toshio Kokubo, Masako Sato, Kosuke Nakashima, Mina Ishimori, Hiroichi Nagai, Ying-Fu Li, Takeshi Yura and Kevin B. Bacon
Journal of Pharmacology and Experimental Therapeutics May 23, 2003, DOI: https://doi.org/10.1124/jpet.103.052316
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement